|
| patients | Baseline | After 3 months | After 6 months | After 12 months |
|
| ESR (mm/h) | 24.5 (5–82)
{95% CI: 14.3–36.0} | 14.0 (3–74)*
{95% CI: 8.0–29.5} | 19.0 (3–120)
{95% CI: 7.5–38.3} | 14.5 (3–94)
{95% CI: 9.8–36.8} |
| CRP (mg/L) | 4.1 (0.2–119)
{95% CI: 2.0–9.2} | 3.0 (0.3–34.8)*
{95% CI: 1.1–5.9} | 3.0 (0.2–38.1)
{95% CI: 1.0–6.8} | 3.6 (0.0–65)
{95% CI: 1.4–7.5} |
| DAS28 | 4.8 (1.6–8.0)
{95% CI: 4.1–6.1} | 4.1 (1.4–7.6)*
{95% CI: 2.9–4.9} | 3.7 (1.1–6.8)*
{95% CI: 2.5–5.2} | 3.8 (1.3–7.1)*
{95% CI: 2.8–4.7} |
Synovitis score in GSUS
(0–27) | 13.0 (7–25)
{95% CI: 0.5–6.5} | 10.0 (3–22)*
{95% CI: 6.5–15.0} | 10.0 (2–18)*
{95% CI: 7.0–13.5} | 9.0 (0–20)*
{95% CI: 6.0–12.0} |
Synovitis score in PDUS
(0–39) | 2.0 (0–16)
{95% CI: 0.5–6.5} | 1.0 (0–20)
{95% CI: 0.0–5.0} | 1.0 (0–18)*
{95% CI: 0.0–3.0} | 2.0 (0–9)*
{95% CI: 0.0–2.5} |
Tenosynovitis/paratenonitis score in GSUS
(0–7) | 1.0 (0–5)
{95% CI: 0.0–1.0} | 0.0 (0–5)
{95% CI: 0.0–1.0} | 0.0 (0–3)*
{95% CI: 0.0–1.0} | 0.0 (0–5)
{95% CI: 0.0–1.0} |
Tenosynovitis/paratenonitis score in PDUS
(0–21) | 0.0 (0–8)
{95% CI: 0.0–0.0} | 0.0 (0–8)
{95% CI: 0.0–0.0} | 0.0 (0–5)
{95% CI: 0.0–0.0} | 0.0 (0–6)
{95% CI: 0.0–0.0} |
Erosions score excluding the wrist
(0–14) | 7.0 (0–14)
{95% CI: 4.0–9.0} | 6.0 (1–14)
{95% CI: 4.0–9.0} | 6.0 (0–14)
{95% CI: 4.0–9.0} | 5.0 (0–11)*
{95% CI: 3.0–7.0} |
Erosions score including the wrist
(0–17) | 8.0 (0–17)
{95% CI: 5.0–11.0} | 7.0 (2–17)
{95% CI: 6.0–11.5} | 8.0 (0–17)
{95% CI: 5.0–11.5} | 6.0 (1–14)*
{95% CI: 5.0–9.0} |
|
